Lupcon
PI: Karen Kristine Sørensen
The project aims to develop a method to control liver uptake that will increase the effectiveness of large-molecule drugs and nanoformulations in the treatment of patients.
Partners:
- Norinnova
- SINTEF
Financing: NFR /NRC Commercialisation Project Verification
VBRG members:
- Karen Kristine Sørensen
- Bård Smedsrød (WP-leader)
- Ruomei Li
- Jaione Simon-Santamaria
- Peter McCourt
interNASH
PI: Gahl Levy
An intercellular-pathway therapeutic for non-alcoholic steatohepatitis. The project aims to develop new methods and approaches to treat NASH
Financing: NFR/NRC Commercialisation Project Qualification
VBRG members:
NANO-BLOCK
PI: Karolina Szafranska
The main obstacle preventing nanomedicine advancement is unwanted uptake by the liver. This project focuses on repurposing medications to block unwanted liver-mediated nanomedicine uptake.
Partners:
- SINTEF
- Norinnova
Financing: UiT Innovation funding
VBRG members: